Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 15.5B | 17.3B | 15.7B | 16.5B |
| Cost of revenue | 9.4B | 11.3B | 9.9B | 10.6B |
| Gross profit | 6.1B | 6.0B | 5.8B | 5.9B |
| Operating expense | ||||
| Research & development | 500M | 513M | 771M | 537M |
| Selling general and admin | 2.2B | 2.2B | 2.1B | 2.4B |
| Other operating expenses | 327M | -142M | -367M | 123M |
| Operating income | 3.1B | 3.4B | 3.3B | 2.9B |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 2.9B | 3.1B | 3.0B | 2.7B |
| Tax provision | 685M | 747M | 690M | 612M |
| Net income | 2.2B | 2.4B | 2.3B | 2.0B |
| Basic EPS | 1.8 | 2.0 | 1.9 | 1.7 |
| Diluted EPS | 1.8 | 2.0 | 1.9 | 1.7 |
| Basic average shares | 1.2B | 1.2B | 1.2B | 1.2B |
| Diluted average shares | 1.2B | 1.2B | 1.2B | 1.2B |
| EBITDA | 3.9B | 4.2B | 4.4B | 3.7B |
| Net income from continuing op. | 3.1B | 3.4B | 3.3B | 2.9B |
| Minority interests | 4M | -16M | -5M | -2M |
| Preferred stock dividends | 0 | 0 | 0 | 0 |